期刊文献+

基于气相色谱-质谱的代谢组学技术研究紫杉醇诱导的卵巢癌A2780耐药株的生物标志物 被引量:4

Metabolomic profiling based on gas chromatography-mass spectrometer(GC-MS) for identification of potential biomarkers in paclitaxel-resistant A2780 ovarian cancer cell
下载PDF
导出
摘要 采用气相色谱-质谱(GC-MS)的代谢组学技术研究人卵巢癌紫杉醇耐药细胞A2780/Taxol与敏感细胞之间内源性代谢物的差异,初步探讨A2780/Taxol细胞生物学特性和耐药机制。使用浓度梯度法建立A2780/Taxol细胞,并通过细胞形态观察,生长曲线测定,药物敏感试验,细胞内多药耐药相关蛋白(MRP1)、P-糖蛋白(P-gp)和肺耐药蛋白(LRP)的水平测定,评价A2780/Taxol细胞的生物学特性。同时,采用GC-MS的代谢组学方法分别对卵巢癌敏感细胞株与紫杉醇耐药细胞株的代谢物指纹图谱进行分析,并通过偏最小二乘法判别分析(PLS-DA)对代谢组学数据进行多元处理。结果表明:人卵巢癌细胞敏感细胞与耐药细胞相比,其中琥珀酸、天冬氨酸、果糖、肌醇等13种内源性代谢物存在显著性差异。糖降解、三羧酸(TCA)循环、肌苷代谢途径发生了异常改变,这些差异改变可能与卵巢癌细胞的耐药机制有关。 Gas chromatography-mass spectrometer (GC-MS) metabolomic was used to identify the differences of potential metabolic between human ovarian cancer paclitaxel-resistant cells (A2780/Taxol) and sensitive ones. Meanwhile, it was used to research biological characteristics and resistance mechanisms of paclitaxel-resistant cells. Paclitaxel-resistant cells were induced by continuous stepwise selection with increasing concentrations of taxol. The biological characteristics were identified by evaluating cell morphology, growth curve, drug susceptibility testing, and intracellular protein expression measurement of multidrug-associated protein ( MRP 1 ), P-glycoprotein (P-gp) and lung resistance protein ( LRP ). GC- MS metabolomics was used to investigate endogenous metabolic changes in A2780 paclitaxel-resistant cells.The metabolic differences of paclitaxel-resistant cells were compared by sensitive cells using partial least squares-discriminant analysis (PLS-DA) score plot analysis. Results showed that significant metabolite differences were also observed between human ovarian cancer paclitaxel-resistant cells and sensitive ones. 13 characteristic metabolites, such as succinic acid, aspartic acid, fructose, and inositol et al were identified. Abnormal alterations in metabolic pathways were identified, namely, the glycolysis, tricarboxylic acid (TCA) cycle, inosine metabolism, ovarian cancer cells.
出处 《南京工业大学学报(自然科学版)》 CAS 北大核心 2016年第1期111-116,共6页 Journal of Nanjing Tech University(Natural Science Edition)
关键词 卵巢癌 紫杉醇 耐药蛋白 代谢组学 :ovarian cancer taxol resistance protein metabolomic
  • 相关文献

参考文献12

  • 1WANG Ningning, ZHAO Lijun, WU Linan, et al. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line [ J ]. Asian pacific journal of cancer prevention, 2013,10(9) :4983.
  • 2MICHELE M, CORTE A, CICCHILLITTI L,et al.A proteomic app-roach to pachtaxel chemoresistance in ovarian cancer cell lines [ J ].Aeta biochimica et biophysica sinica, 2009,1794 (2) : 225.
  • 3SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics, 2013 [ J ]. A cancer journal for clinicians, 2013,63 ( 1 ) : 11.
  • 4YAN Bei, JIYE A, WANG Guangji, et al. Metabolomic investigation into variation of endogenous metabolites in professional athletes subject to strength-endurance training [ J ]. Journal of applied physiology, 2009,106 (2) : 531.
  • 5黄以萍,徐丛剑.代谢组学在卵巢癌中的应用研究进展[J].现代妇产科进展,2008,17(5):379-381. 被引量:1
  • 6张洪新,郭卫平,王执民,王义清,刘燕,关彦,李文献,倪代慧.人肝癌细胞耐药模型-7721/Adm的建立及其部分生物学特性[J].癌症,2000,19(8):748-751. 被引量:32
  • 7史栋栋,况媛媛,王桂明,彭章晓,王彦,阎超.细胞代谢组学用于羽扇豆醇干预人乳腺癌细胞MCF-7的机理探究[J].色谱,2014,32(3):278-283. 被引量:19
  • 8MIZUTANI T, MASUDA M, NAKAI E, et al.Genuine functions of P-glycoprotein (ABCB1) [ J ]. Current drug metabolism, 2008, 9(2) :167.
  • 9SAUER H, ENGEL S, MILOSEVIC N, et al.Activation of AMP- kinase by AICAR induces apoptosis of DU-145 prostate cancer ceils through generation of reactive oxygen species and activation of c-Jun N-terminal kinase [ J ]. International journal of oncology, 2012,40(2) :501.
  • 10LOAR P, WAHL H, KSHIRSAGAR M, et al. Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells [ J ]. American journal of obstetrics and gynecology, 2010, 202(4) :351.

二级参考文献44

  • 1Schinkel AH,Jonker JW.Mammalian drug efflux transporters of the ATP bindingi cassette(ABC)family:an overview.Adv Drug Deliv Rev,2003,55(1):3-29.
  • 2Kusuhara H,Sugiyama Y.Role of transporters in the tissue-selective distribution and elimination of drugs:transporters in the liver,small intestine,brain and kidney,J Control Release,2002,78(1-3):43-54.
  • 3Siegsmund M,Brinkmann U,Scháffeler E,et al.Association of the P-glycoprotein transporter MDR1(C3435T)polymorphism with the susceptibility to renal epithelial tumors.J Am Soc Nephrol,2002,13(7):1847-1854.
  • 4Lee W,Kim RB.Transporters and renal drug elimination.Annu Rev Pharmacol Toxicol,2004,44:137-166.
  • 5O'C onnor R,Heenan M,C onnolly L,et al.Increased anti-tumour efficacy of doxorubicin when cornbineld with sulindac in a xenografl model of an MRP-1-positive human lung cancer.Anticancer Res,2004,24(2A):457-464.
  • 6Haimeur A,Conseil G,Deeley RG,et al.The MRP-related and BCRP/ABC G2 muhidrug resistance proteins:biology,substrate specificity and regulation.Curr Drug Metab,2004,5(1):21-53.
  • 7Zelcer N,Saeki T,Reid G,et al.Characterization of drug transport by the human muhidrug resistance protein 3(ABCC3).J Biol Chem,200 1,276(49):46400-46407.
  • 8Wijnholds J,Mol CA,van Deemter L,et al.Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs.Proc Natl Acad Sci U S A,2000,97(13):7476-7481.
  • 9Bouhamyia L,Chantot-Bastaraud S,Zaidi S,et al.Immunolocalization and cell expression of lung resistance-related protein(LRP)in normal and tumoral human respiratory cells.J Histochem Cytochem,2007,55(8):773-782.
  • 10Coley HM,Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer.Cancer Treat Rev,2008,34(4):378-390.

共引文献59

同被引文献30

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部